KEGG   PATHWAY: tge05206
Entry
tge05206                    Pathway                                
Name
MicroRNAs in cancer - Theropithecus gelada (gelada)
Description
MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.
Class
Human Diseases; Cancer: overview
Pathway map
tge05206  MicroRNAs in cancer
tge05206

Organism
Theropithecus gelada (gelada) [GN:tge]
Gene
112631315  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
112634261  CDKN1B; cyclin-dependent kinase inhibitor 1B isoform X1 [KO:K06624]
112632754  TIMP3; metalloproteinase inhibitor 3 isoform X1 [KO:K16866]
112634105  KRAS; GTPase KRas isoform X1 [KO:K07827]
112620347  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
112618658  CDC25A; M-phase inducer phosphatase 1 isoform X1 [KO:K06645] [EC:3.1.3.48]
112633719  CDC25B; M-phase inducer phosphatase 2 isoform X1 [KO:K05866] [EC:3.1.3.48]
112625735  CDC25C; M-phase inducer phosphatase 3 isoform X1 [KO:K05867] [EC:3.1.3.48]
112635125  HMGA2; high mobility group protein HMGI-C isoform X1 [KO:K09283]
112605640  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
112634321  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
112629797  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
112612586  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
112609430  CRK; adapter molecule crk isoform X1 [KO:K04438]
112632798  CRKL; crk-like protein isoform X1 [KO:K04438]
112636344  HDAC4; histone deacetylase 4 [KO:K11406] [EC:3.5.1.98]
112609417  HDAC5; histone deacetylase 5 isoform X1 [KO:K11406] [EC:3.5.1.98]
112618123  FOXP1; forkhead box protein P1 isoform X1 [KO:K23582]
112623408  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
112620574  MET; hepatocyte growth factor receptor isoform X1 [KO:K05099] [EC:2.7.10.1]
112605006  DNMT3A; DNA (cytosine-5)-methyltransferase 3A isoform X1 [KO:K17398] [EC:2.1.1.37]
112632847  DNMT3B; DNA (cytosine-5)-methyltransferase 3B isoform X1 [KO:K17399] [EC:2.1.1.37]
112613772  MCL1; induced myeloid leukemia cell differentiation protein Mcl-1 isoform X1 [KO:K02539]
112628440  BCL2L2; bcl-2-like protein 2 [KO:K02163]
112620091  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
112622794  VEGFA; vascular endothelial growth factor A isoform X1 [KO:K05448]
112631278  ZEB1; zinc finger E-box-binding homeobox 1 isoform X1 [KO:K09299]
112636300  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
112622460  EZR; ezrin isoform X1 [KO:K08007]
112632085  PDCD4; programmed cell death protein 4 isoform X1 [KO:K16865]
112614062  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
112632825  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
112627642  TPM1; tropomyosin alpha-1 chain isoform X1 [KO:K10373]
112611151  SPRY2; protein sprouty homolog 2 [KO:K17383]
112611529  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
112611638  SERPINB5; serpin B5 [KO:K10139]
112607139  ST14; suppressor of tumorigenicity 14 protein [KO:K08670] [EC:3.4.21.109]
112637014  cytochrome P450 1B1 isoform X1 [KO:K07410] [EC:1.14.14.1]
112623568  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
112609602  RPTOR; regulatory-associated protein of mTOR isoform X1 [KO:K07204]
112632353  1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1 [KO:K07436] [EC:1.14.15.16]
112608971  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
112634585  ERBB3; receptor tyrosine-protein kinase erbB-3 [KO:K05084] [EC:2.7.10.1]
112607912  ABL1; tyrosine-protein kinase ABL1 isoform X1 [KO:K06619] [EC:2.7.10.2]
112619228  TP63; tumor protein 63 isoform X1 [KO:K10149]
112636126  ZEB2; zinc finger E-box-binding homeobox 2 isoform X1 [KO:K23560]
112634457  FSCN1; fascin isoform X1 [KO:K23551]
112619231  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
112636191  HOXD10; homeobox protein Hox-D10 [KO:K09295]
112631165  DDIT4; DNA damage-inducible transcript 4 protein [KO:K08270]
112627755  BMF; bcl-2-modifying factor isoform X1 [KO:K17460]
112612922  PAK4; serine/threonine-protein kinase PAK 4 isoform X1 [KO:K05734] [EC:2.7.11.1]
112632530  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
112610746  SLC7A1; high affinity cationic amino acid transporter 1 [KO:K13863]
112625792  CCNG1; cyclin-G1 isoform X1 [KO:K10145]
112633215  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
112630238  STMN1; stathmin isoform X1 [KO:K04381]
112608953  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
112630275  MYC; myc proto-oncogene protein [KO:K04377]
112622580  LOW QUALITY PROTEIN: caspase-3-like [KO:K02187] [EC:3.4.22.56]
112625066  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
112607359  HRAS; GTPase HRas isoform X1 [KO:K02833]
112619416  NRAS; GTPase NRas isoform X1 [KO:K07828]
112613572  DNMT1; DNA (cytosine-5)-methyltransferase 1 isoform X1 [KO:K00558] [EC:2.1.1.37]
112612730  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
112625954  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
112636552  IRS1; insulin receptor substrate 1 [KO:K16172]
112614522  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
112625914  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
112612001  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
112609132  MAPK7; mitogen-activated protein kinase 7 isoform X1 [KO:K04464] [EC:2.7.11.24]
112618874  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
112634042  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
112619294  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
112608494  HNRNPK; heterogeneous nuclear ribonucleoprotein K isoform X1 [KO:K12886]
112607859  RECK; reversion-inducing cysteine-rich protein with Kazal motifs [KO:K17461]
112623737  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
112610905  IRS2; insulin receptor substrate 2 [KO:K07187]
112607929  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
112618263  NOTCH2; neurogenic locus notch homolog protein 2 isoform X1 [KO:K20994]
112612025  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
112622564  NOTCH4; neurogenic locus notch homolog protein 4 [KO:K20996]
112631093  BMI1; polycomb complex protein BMI-1 [KO:K11459]
112630111  MMP16; matrix metalloproteinase-16 [KO:K07996] [EC:3.4.24.-]
112606480  ATM; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
112614217  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]
112606160  CD44; CD44 antigen isoform X1 [KO:K06256]
112628686  DICER1; endoribonuclease Dicer isoform X1 [KO:K11592] [EC:3.1.26.-]
112630226  FZD3; frizzled-3 [KO:K02329]
112633971  ITGA5; integrin alpha-5 [KO:K06484]
112606121  RDX; radixin isoform X1 [KO:K05762]
112622050  transforming protein RhoA-like isoform X1 [KO:K04513]
112608311  RHOC; rho-related GTP-binding protein RhoC isoform X1 [KO:K04513]
112618614  RHOA; transforming protein RhoA isoform X1 [KO:K04513]
112631372  PLAU; urokinase-type plasminogen activator [KO:K01348] [EC:3.4.21.73]
112622824  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
112629952  ZFPM2; zinc finger protein ZFPM2 isoform X1 [KO:K17442]
112609798  ITGB3; integrin beta-3 isoform X1 [KO:K06493]
112614045  UBE2I; SUMO-conjugating enzyme UBC9 [KO:K10577]
112622296  SOX4; transcription factor SOX-4 isoform X1 [KO:K23581]
112636246  TNN; tenascin-N [KO:K06252]
112607867  TNC; tenascin isoform X1 [KO:K06252]
112622563  TNXB; tenascin-X [KO:K06252]
112631430  TNR; tenascin-R isoform X1 [KO:K06252]
112620648  ABCB1; multidrug resistance protein 1 [KO:K05658] [EC:7.6.2.2]
112614286  ABCC1; multidrug resistance-associated protein 1 [KO:K05665] [EC:7.6.2.3]
112610045  BRCA1; breast cancer type 1 susceptibility protein isoform X1 [KO:K10605] [EC:2.3.2.27]
112623750  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X1 [KO:K06625]
112624372  EFNA1; ephrin-A1 isoform X1 [KO:K05462]
112610717  EFNA3; ephrin-A3 isoform X1 [KO:K05462]
112611866  EFNA2; ephrin-A2 [KO:K05462]
112626705  EFNA5; ephrin-A5 [KO:K05462]
112612330  EFNA4; LOW QUALITY PROTEIN: ephrin-A4 [KO:K05462]
112628028  THBS1; thrombospondin-1 isoform X1 [KO:K16857]
112610224  IGF2BP1; insulin-like growth factor 2 mRNA-binding protein 1 isoform X1 [KO:K17391]
112619209  TRIM71; E3 ubiquitin-protein ligase TRIM71 [KO:K12035] [EC:2.3.2.27]
112624752  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
112629970  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
112611851  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
112614214  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
112632792  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
112609643  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
112614190  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
112613317  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
112608918  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
112625207  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
112628450  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
112610199  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
112634274  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
112608959  MDM4; protein Mdm4 isoform X1 [KO:K10127]
112625154  PDGFRA; platelet-derived growth factor receptor alpha isoform X1 [KO:K04363] [EC:2.7.10.1]
112632711  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
112614034  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
112619721  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
112627624  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
112612394  MAP2K2; LOW QUALITY PROTEIN: dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
112628758  SOS2; LOW QUALITY PROTEIN: son of sevenless homolog 2 [KO:K03099]
112604731  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
112628791  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
112620011  PDGFA; platelet-derived growth factor subunit A [KO:K04359]
112627393  SHC4; SHC-transforming protein 4 [KO:K17449]
112633086  PDGFB; platelet-derived growth factor subunit B [KO:K17386]
112626117  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
112607787  cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
112607790  tumor suppressor ARF-like [KO:K06621]
112632890  E2F1; transcription factor E2F1 [KO:K17454]
112629771  E2F2; transcription factor E2F2 [KO:K09389]
112605166  BCL2L11; bcl-2-like protein 11 [KO:K16341]
112622213  MARCKS; myristoylated alanine-rich C-kinase substrate isoform X1 [KO:K12561]
112636031  BMPR2; bone morphogenetic protein receptor type-2 [KO:K04671] [EC:2.7.11.30]
112612633  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
112622370  HDAC2; histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
112620861  EZH2; histone-lysine N-methyltransferase EZH2 isoform X1 [KO:K11430] [EC:2.1.1.356]
112635951  GLS; glutaminase kidney isoform, mitochondrial isoform X1 [KO:K01425] [EC:3.5.1.2]
112634835  GLS2; glutaminase liver isoform, mitochondrial isoform X1 [KO:K01425] [EC:3.5.1.2]
112632129  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
112609646  WNT3; proto-oncogene Wnt-3 [KO:K00312]
112616995  protein Wnt-3a [KO:K00312]
112617012  protein Wnt-3a [KO:K00312]
112606446  CDCA5; sororin isoform X1 [KO:K17390]
112627546  KIF23; kinesin-like protein KIF23 isoform X1 [KO:K17387]
112611421  ROCK1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.39]
112604800  PRKCE; protein kinase C epsilon type [KO:K18050] [EC:2.7.11.13]
112628038  SLC45A3; solute carrier family 45 member 3 [KO:K15379]
112631254  VIM; vimentin [KO:K07606]
Reference
  Authors
Lee YS, Dutta A
  Title
MicroRNAs in cancer.
  Journal
Annu Rev Pathol 4:199-227 (2009)
DOI:10.1146/annurev.pathol.4.110807.092222
Reference
  Authors
Babashah S, Soleimani M
  Title
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
  Journal
Eur J Cancer 47:1127-37 (2011)
DOI:10.1016/j.ejca.2011.02.008
Reference
  Authors
Garzon R, Calin GA, Croce CM
  Title
MicroRNAs in Cancer.
  Journal
Annu Rev Med 60:167-79 (2009)
DOI:10.1146/annurev.med.59.053006.104707
Reference
  Authors
Chen PS, Su JL, Hung MC
  Title
Dysregulation of microRNAs in cancer.
  Journal
J Biomed Sci 19:90 (2012)
DOI:10.1186/1423-0127-19-90
Reference
  Authors
Ling H, Zhang W, Calin GA
  Title
Principles of microRNA involvement in human cancers.
  Journal
Chin J Cancer 30:739-48 (2011)
DOI:10.5732/cjc.011.10243
Reference
  Authors
Iorio MV, Croce CM
  Title
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.
  Journal
EMBO Mol Med 4:143-59 (2012)
DOI:10.1002/emmm.201100209
Reference
  Authors
Sayed D, Abdellatif M
  Title
MicroRNAs in development and disease.
  Journal
Physiol Rev 91:827-87 (2011)
DOI:10.1152/physrev.00006.2010
Reference
  Authors
Wang Q, Wang S, Wang H, Li P, Ma Z
  Title
MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
  Journal
Exp Biol Med (Maywood) 237:227-35 (2012)
DOI:10.1258/ebm.2011.011192
Reference
  Authors
Song JH, Meltzer SJ
  Title
MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
  Journal
Gastroenterology 143:35-47.e2 (2012)
DOI:10.1053/j.gastro.2012.05.003
Reference
  Authors
Chu Y, Zhu H, Lv L, Zhou Y, Huo J
  Title
MiRNA s in oesophageal squamous cancer.
  Journal
Neth J Med 71:69-75 (2013)
Reference
  Authors
Kan T, Meltzer SJ
  Title
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
  Journal
Curr Opin Pharmacol 9:727-32 (2009)
DOI:10.1016/j.coph.2009.08.009
Reference
  Authors
Smith CM, Watson DI, Michael MZ, Hussey DJ
  Title
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
  Journal
World J Gastroenterol 16:531-7 (2010)
DOI:10.3748/wjg.v16.i5.531
Reference
  Authors
Song S, Ajani JA
  Title
The role of microRNAs in cancers of the upper gastrointestinal tract.
  Journal
Nat Rev Gastroenterol Hepatol 10:109-18 (2013)
DOI:10.1038/nrgastro.2012.210
Reference
  Authors
Liu WH, Yeh SH, Chen PJ
  Title
Role of microRNAs in hepatitis B virus replication and pathogenesis.
  Journal
Biochim Biophys Acta 1809:678-85 (2011)
DOI:10.1016/j.bbagrm.2011.04.008
Reference
  Authors
Hrasovec S, Glavac D
  Title
MicroRNAs as Novel Biomarkers in Colorectal Cancer.
  Journal
Front Genet 3:180 (2012)
DOI:10.3389/fgene.2012.00180
Reference
  Authors
Liu H
  Title
MicroRNAs in breast cancer initiation and progression.
  Journal
Cell Mol Life Sci 69:3587-99 (2012)
DOI:10.1007/s00018-012-1128-9
Reference
  Authors
Li SD, Zhang JR, Wang YQ, Wan XP
  Title
The role of microRNAs in ovarian cancer initiation and progression.
  Journal
J Cell Mol Med 14:2240-9 (2010)
DOI:10.1111/j.1582-4934.2010.01058.x
Reference
  Authors
Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA
  Title
Characteristic patterns of microRNA expression in human bladder cancer.
  Journal
Front Genet 3:310 (2012)
DOI:10.3389/fgene.2012.00310
Reference
  Authors
Saini S, Majid S, Dahiya R
  Title
Diet, microRNAs and prostate cancer.
  Journal
Pharm Res 27:1014-26 (2010)
DOI:10.1007/s11095-010-0086-x
Related
pathway
tge05210  Colorectal cancer
tge05214  Glioma
tge05215  Prostate cancer
tge05219  Bladder cancer
tge05222  Small cell lung cancer
tge05223  Non-small cell lung cancer
KO pathway
ko05206   
LinkDB

DBGET integrated database retrieval system